Literature DB >> 22088335

Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma.

William R Sukov1, Christine M Lohse, Bradley C Leibovich, R Houston Thompson, John C Cheville.   

Abstract

PURPOSE: We determined the clinical and pathological features associated with death from papillary renal cell carcinoma in 395 surgically treated patients.
MATERIALS AND METHODS: Papillary renal cell carcinoma tissue slides from each patient were reviewed for type (1 or 2), grade, TNM stage, coagulative tumor necrosis and sarcomatoid differentiation. Associations of clinical and pathological features with death from renal cell carcinoma were evaluated using Cox proportional hazards regression models and summarized by the HR and 95% CI. Cancer specific survival was estimated using the Kaplan-Meier method.
RESULTS: Univariate analysis revealed that symptoms, tumor thrombus, tumor size, perinephric/renal sinus fat invasion, 2010 primary tumor classification, regional lymph node involvement, distant metastasis, 2010 TNM stage group, grade, tumor necrosis, sarcomatoid differentiation and papillary renal cell carcinoma type were associated with death from renal cell carcinoma. Grade was more strongly associated with death from renal cell carcinoma than papillary renal cell carcinoma type. Multivariate analysis indicated that symptoms, 2010 TNM stage group and grade jointly were significantly associated with death from renal cell carcinoma.
CONCLUSIONS: This large series of patients with papillary renal cell carcinoma reveals features associated with death from renal cell carcinoma and confirms that grade is more predictive of outcome than papillary renal cell carcinoma type.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22088335     DOI: 10.1016/j.juro.2011.09.053

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  34 in total

1.  Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.

Authors:  Reza Mehrazin; Robert G Uzzo; Alexander Kutikov; Karen Ruth; Jeffrey J Tomaszewski; Essel Dulaimi; Serge Ginzburg; Philip H Abbosh; Timothy Ito; Anthony T Corcoran; David Y T Chen; Marc C Smaldone; Tahseen Al-Saleem
Journal:  Urol Oncol       Date:  2014-07-11       Impact factor: 3.498

2.  Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Authors:  Brett Delahunt; Lars Egevad; John R Srigley; Hemamali Samaratunga
Journal:  World J Urol       Date:  2017-12-18       Impact factor: 4.226

3.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.

Authors:  Kirk A Keegan; Clayton W Schupp; Karim Chamie; Nicholas J Hellenthal; Christopher P Evans; Theresa M Koppie
Journal:  J Urol       Date:  2012-06-13       Impact factor: 7.450

4.  [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].

Authors:  E S Bo; P Hong; Y Zhang; S H Deng; L Y Ge; M Lu; N Li; L L Ma; S D Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

5.  Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.

Authors:  Rodrigo A Ledezma; Edris Negron; Gladell P Paner; Chris Rjepaj; Danny Lascano; Mohammed Haseebuddin; Pankaj Dangle; Arieh L Shalhav; Henry Crist; Jay D Raman; G Joel DeCastro; Lara Harik; Monika Paroder; Robert G Uzzo; Alexander Kutikov; Scott E Eggener
Journal:  World J Urol       Date:  2015-09-25       Impact factor: 4.226

Review 6.  Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Authors:  Theodore F Logan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

7.  Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.

Authors:  Daniel P Nguyen; Emily A Vertosick; Renato B Corradi; Antoni Vilaseca; Nicole E Benfante; Karim A Touijer; Daniel D Sjoberg; Paul Russo
Journal:  Urol Oncol       Date:  2016-03-02       Impact factor: 3.498

8.  Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.

Authors:  Joshua I Warrick; Alex Tsodikov; Lakshmi P Kunju; Arul M Chinnaiyan; Ganesh S Palapattu; Todd M Morgan; Ajjai Alva; Scott Tomlins; Angela Wu; Jeffrey S Montgomery; Khaled S Hafez; J Stuart Wolf; Alon Z Weizer; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-02-20       Impact factor: 3.466

9.  Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.

Authors:  Liang Luo; Haiyi Zhou; Hao Su
Journal:  BMC Cancer       Date:  2021-05-17       Impact factor: 4.430

10.  The first competing risk survival nomogram in patients with papillary renal cell carcinoma.

Authors:  Xing Su; Niu-Niu Hou; Li-Jun Yang; Peng-Xiao Li; Xiao-Jian Yang; Guang-Dong Hou; Xue-Lin Gao; Shuai-Jun Ma; Fan Guo; Rui Zhang; Wu-He Zhang; Wei-Jun Qin; Fu-Li Wang
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.